SavedAdd your journal

Journals / Turkish Journal of Gastroenterology / 2020 / Cilt: 31 - Sayı: 1

Submucosal tunneling endoscopic resection for large symptomatic submucosal tumors of the esophagus: A clinical analysis of 24 cases

Guo-Xiang WANG
Guang YU
Yan-Li XIANG
Yang-De MIU
Hong-Gang WANG
Mei-Dong XU
Pages
42–48
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There were no residual lesions or disease recurrence duringfollow-up.Conclusion: STER is safe and effective for the treatment of large symptomatic SMTs of muscularis propria layer origin in the esophagus.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background/Aims: Studies evaluating submucosal tunneling endoscopic resection (STER) for the treatment of upper gastrointestinalsubmucosal tumors (SMTs) have recently increased.
📊
Key Findings & Data:The aim of the present study was to evaluate the efficacy and safety of STERfor the treatment of large symptomatic SMTs in the esophagus.Methods: A total of 24 patients with large symptomatic SMTs in the esophagus who underwent STER in our hospitals between January2015 and May 2018 were included in the study.
💡
Conclusion & Impact:There were no residual lesions or disease recurrence duringfollow-up.Conclusion: STER is safe and effective for the treatment of large symptomatic SMTs of muscularis propria layer origin in the esophagus.
🔬Design:Research Article
📍Scope:2018 Verileri
⚙️Variables:Domain Parameters

Özet

Background/Aims: Studies evaluating submucosal tunneling endoscopic resection (STER) for the treatment of upper gastrointestinalsubmucosal tumors (SMTs) have recently increased. However, the efficacy and safety of STER for the treatment of large symptomaticSMTs in the esophagus have not been well investigated. The aim of the present study was to evaluate the efficacy and safety of STERfor the treatment of large symptomatic SMTs in the esophagus.Methods: A total of 24 patients with large symptomatic SMTs in the esophagus who underwent STER in our hospitals between January2015 and May 2018 were included in the study. The tumors were confirmed to be of muscularis propria layer origin. Treatment outcomes,complications, and follow-up results were retrospectively analyzed.Results: All 24 lesions were resected en bloc with STER. The mean maximum transverse diameter of the lesions was 4.7 (3.5–6.5) cm.The mean maximum longitudinal diameter of the lesions was 2.1 (1.5–3.0) cm. The mean duration from mucosal incision to completemucosal closure was 65 (50–115) min. Postoperative pathological diagnosis confirmed 18 cases with leiomyomas, 4 cases with stromaltumors, and 2 cases with schwannomas. There were no major complications. There were no residual lesions or disease recurrence duringfollow-up.Conclusion: STER is safe and effective for the treatment of large symptomatic SMTs of muscularis propria layer origin in the esophagus.

🔖

Cite This Article

WANG, G., YU, G., XIANG, Y., MIU, Y., WANG, H., XU, M. (2020). Submucosal tunneling endoscopic resection for large symptomatic submucosal tumors of the esophagus: A clinical analysis of 24 cases. Turkish Journal of Gastroenterology, Cilt: 31 - Sayı: 1, 42–48. https://ajindex.com/articles/409194

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Nishida T, Hirota S, Yanagisawa A, et al. Clinical practice guidelines for gastrointestinal stromal tumor (GIST) in Japan: English version. Int J Clin Oncol 2008; 13: 416-30
  2. Karaca C, Turner BG, Cizginer S, et al. Accuracy of EUS in the evaluation of small gastric subepithelial lesions.Gastrointest Endosc 2010; 71: 722-7
  3. Hong JB, Choi CW, Kim HW, et al. Endoscopic resection using band ligation for esophageal SMT in less than 10 mm. World J Gastroenterol 2015; 21: 2982-7
  4. Xu MD, Cai MY, Zhou PH, et al. Submucosal tunneling endoscopic resection: a new technique for treating upper GI submucosal tumors originating from the muscularis propria layer (with videos). Gastrointest Endosc 2012; 75: 195-9
  5. Wang XY, Xu MD, Yao LQ, et al. Submucosal tunneling endoscopic resection for submucosal tumors of the esophagogastric junction originating from the muscularis propria layer: a feasibility study (with videos). Surg Endosc 2014; 28: 1971-7
  6. Ye LP, Zhang Y, Mao XL, et al. Submucosal tunneling endoscopic resection for small upper gastrointestinal subepithelial tumors originating from the muscularis propria layer.Surg Endosc 2014; 28: 524-30
  7. Chen H, Xu Z, Huo J, et al. Submucosal tunneling endoscopic resection for simultaneous esophageal and cardia submucosal tumors originating from the muscularis propria layer (with video). Dig Endosc 2015; 27: 155-8
  8. Kumbhari V, Saxena P, Azola A, et al. Submucosal tunneling endoscopic resection of a giant esophageal leiomyoma. Gastrointest Endosc 2015; 81: 219-20
  9. Lu J, Jiao T, Zheng M, et al. Endoscopic resection of submucosal tumors in muscularis propria: The choice between direct excavation and tunneling resection. Surg Endosc 2014; 28: 3401-7
  10. Ponsaing LG, Kiss K, Hansen MB, et al. Classification of submucosal tumors in the gastrointestinal tract. World J Gastroenterol 2007; 13: 3311-5
  11. Tomoaki A, Tetsu N, Taro O, et al. Strategy for esophageal nonepithelial tumors based on a retrospective analysis of a single facility. Esophagus 2018; 15: 286-93
  12. Young Kwan Cho and Seong Hwan Kim.Current Status of Peroral Endoscopic Myotomy. Clin Endosc 2018; 51: 13-8
  13. Pimentel-Nunes P, Dinis-Ribeiro M, Ponchon T, et al. Endoscopic submucosal dissection: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2015; 47: 829-54
  14. Ma MX, Bourke MJ. Endoscopic submucosal dissection in the West: Current status and future directions. Dig Endosc 2018; 30: 310-20
  15. Chen T, Zhang C, Li